CoChat

The effectiveness of nonsteroidal anti-inflammatory drugs and acetaminophen in reduce the risk of amyotrophic lateral sclerosis? A meta-analysis

Open access

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

To test the hypothesis that aspirin, non-aspirin nonsteroidal anti-infammatory drugs (NA-NSAIDs), or acetaminophen can reduce the risk of ALS, we conducted a systematic review and meta-analysis of related previous studies. A comprehensive search was conducted on the PubMed, Embase, Cochrane Library and SCOPUS databases. It included studies published up to 29 February 2020 that fulfilled our inclusion criteria. Aspirin, acetaminophen and NA-NSAIDs use information, between the ALS and control groups, was collected for the meta-analysis. Rates of aspirin, NA-NSAID, and acetaminophen use in ALS group, compared with control group were investigated. In the results, only three studies that relate the risk of ALS to aspirin, NA-NSAIDs and acetaminophen use satisfied the inclusion criteria for the meta-analysis. Regarding aspirin, the studies did not show any statistically significant difference in aspirin use between the ALS and control groups (Odds ratio, 1.04 [95% confidence interval, 0.90–1.21]). NA-NSAIDs and acetaminophen use, however, did show up statistically significant differences in between the ALS and control groups. (Odds ratio, 0.82 [95% confidence interval, 0.73–0.91]) and (Odds ratio, 0.80 [95% confidence interval, 0.69–0.93]). However, our study has some limitations. Firstly, we only included a small number of studies. Secondly, the included studies did not control for past medical history, which may have confounded their results, and in turn, could have caused bias in our study. Thirdly, in this meta-analysis, the ALS patients were not subdivided into sporadic or familial type. Lastly, the studies also did not consider the types of NSAIDs and dosages used of each drug. For more convincing evidence regarding the effectiveness of aspirin, NA-NSAIDs and acetaminophen to reduce the risk of ALS occurrence, more qualified prospective studies are required. In conclusion, the use of NA-NSAIDs and acetaminophen is associated with a decreased risk for the development of ALS. In contrast, aspirin did not have any effect on the reduction of the risk of ALS occurrence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-020-71813-1

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flowchart showing the search results of the meta-analysis.
Figure 1 Flowchart showing the search results of the meta-analysis.CC BY · PubMed Central
Figure 2 Forest plot of aspirin, non-aspirin non-steroidal anti-inflammatory drugs (NA-NSAIDs), and acetaminophen use in patients with amyotrophic lateral sclerosis versus controls. Note: Three studies were included. Regarding to aspirin, there was no statistically significant difference in aspirin use between the ALS and controls groups (Odds ratio, 1.04 [95% confidence interval, 0.90–1.21]) (A). Regarding to non-aspirin NSAIDs and acetaminophen, however, there were statistically significant differences in NA-NSAIDs (B) and acetaminophen (C) use between the ALS and controls groups. (Odds ratio, 0.82 [95% confidence interval, 0.73–0.91]) vs. (Odds ratio, 0.80 [95% confidence interval, 0.69–0.93]).
Figure 2 Forest plot of aspirin, non-aspirin non-steroidal anti-inflammatory drugs (NA-NSAIDs), and acetaminophen use in patients with amyotrophic lateral sclerosis versus controls. Note: Three studies were included. Regarding to aspirin, there was no statistically significant difference in aspirin use between the ALS and controls groups (Odds ratio, 1.04 [95% confidence interval, 0.90–1.21]) (A). Regarding to non-aspirin NSAIDs and acetaminophen, however, there were statistically significant differences in NA-NSAIDs (B) and acetaminophen (C) use between the ALS and controls groups. (Odds ratio, 0.82 [95% confidence interval, 0.73–0.91]) vs. (Odds ratio, 0.80 [95% confidence interval, 0.69–0.93]).CC BY · PubMed Central
Figure 3 Graphic funnel plot of included studies. Aspirin (A), NA-NSAIDs (B), and acetaminophen (C).
Figure 3 Graphic funnel plot of included studies. Aspirin (A), NA-NSAIDs (B), and acetaminophen (C).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Cited by

See all 17

Metadata

Authors
Chang, M. C., Kwak, S. G., Park, J.-S., & Park, D.
Affiliations
  • Yeungnam University College (KR)
  • Daegu Catholic University (KR)
  • Kyungpook National University (KR)
  • University of Ulsan (KR)
Corresponding author
Park, Donghwi
Venue
Scientific Reports
Published
2020-09-08
Volume
10
Issue
1
Pages
14759-14759
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3084260015
Cited by
17
References
42
Citations by year
2025: 3 · 2024: 5 · 2023: 2 · 2022: 3 · 2021: 4
FWCI
0.25
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Research Foundation of Korea (2019M3E5D1A02068106)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
amyotrophic lateral sclerosis, aspirin, nonsteroidal anti-inflammatory drugs, paracetamol, sporadic ALS, familial ALS, neuroprotection
MeSH terms
Acetaminophen, Amyotrophic Lateral Sclerosis, Animals, Anti-Inflammatory Agents, Non-Steroidal, Drug Therapy, Combination, Humans, Analgesics, Non-Narcotic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effectiveness of nonsteroidal anti-inflammatory drugs and acetaminophen in reduce the risk of amyotrophic lateral sclerosis? A meta-analysis. https://app.cochat.ai/papers/10.1038/s41598-020-71813-1
The paper
Chang, M. C., Kwak, S. G., Park, J.-S., & Park, D. (2020). The effectiveness of nonsteroidal anti-inflammatory drugs and acetaminophen in reduce the risk of amyotrophic lateral sclerosis? A meta-analysis. Scientific Reports. https://doi.org/10.1038/s41598-020-71813-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.